Aerovate Therapeutics, Inc. (AVTE): Price and Financial Metrics

Aerovate Therapeutics, Inc. (AVTE): $2.79

0.34 (+13.88%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add AVTE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#217 of 328

in industry

AVTE Price/Volume Stats

Current price $2.79 52-week high $32.42
Prev. close $2.45 52-week low $1.25
Day low $2.49 Volume 2,795,500
Day high $2.80 Avg. volume 629,947
50-day MA $2.05 Dividend yield N/A
200-day MA $12.26 Market Cap 80.54M

AVTE Stock Price Chart Interactive Chart >


Aerovate Therapeutics, Inc. (AVTE) Company Bio


Aerovate Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs that enhance the lives of patients with rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.


AVTE Latest News Stream


Event/Time News Detail
Loading, please wait...

AVTE Latest Social Stream


Loading social stream, please wait...

View Full AVTE Social Stream

AVTE Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!